Opendata, web and dolomites

Schizo-EPICOG SIGNED

Inflammatory processes underlying cognitive deficits in schizophrenia: epigenetic mechanisms and pharmacological regulation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Schizo-EPICOG project word cloud

Explore the words cloud of the Schizo-EPICOG project. It provides you a very rough idea of what is the project "Schizo-EPICOG" about.

drug    mechanism    suggested    clinically    inflammatory    induce    emerge    free    followed    prognostic    hyperactivity    clozapine    effect    treatments    atypical    histone    markers    double    cortex    mechanisms    prefrontal    treatment    preliminary    hdac    activation    antipsychotics    protein    signalling    gestation    model    patients    psychotic    acetylation    puberty    disease    epigenetic    suspected    hit    stressful    symptoms    inmmune    event    gene    resistant    nuclear    modulation    data    possibility    expression    behavioural    deacetylases    etiopathogenesis    mouse    molecular    alterations    tests    deficits    vulnerability    validated    social    saha    proteins    indicate    maternal    minocycline    neuroinflammation    antipsychotic    postmortem    physio    neuroinflammmatory    human    neuroinflammatory    isolation    involvement    matched    regulation    chronic    cognitive    worsen    inductor    animal    schizophrenic    excess    controls    schizophrenia    phenomenon    peripuberty    subjects    hdacs    prenatal    psychopathology    traslational    inhibitor    relationship    priming    status   

Project "Schizo-EPICOG" data sheet

The following table provides information about the project.

Coordinator
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA 

Organization address
address: BARRIO SARRIENA S N
city: LEIOA
postcode: 48940
website: www.ehu.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 158˙121 €
 EC max contribution 158˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-04-11   to  2020-04-10

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA ES (LEIOA) coordinator 158˙121.00

Map

 Project objective

'Cognitive deficits represent nuclear symptoms of schizophrenia and are considered prognostic factors of the disease. Moreover, they are resistant to the currently available treatments and it is clinically suspected that atypical antipsychotics might worsen cognitive conditions of schizophrenic patients. Preliminary data indicate the involvement of epigenetic regulation of histone deacetylases (HDACs) in this effect and the possibility of neuroinflammmatory activity as the inductor mechanism. In the etiopathogenesis of schizophrenia a double-hit phenomenon has been suggested. Thus, a prenatal priming event that would induce vulnerability is followed by a second stressful hit in peripuberty. Physio- and psychopathology could emerge from these mechanisms through neuroinflammatory hyperactivity. The aim of the present project is to study the relationship between cognitive deficits and neuroinflammatory activity in a traslational 'double hit' mouse model based on the maternal inmmune activation during gestation followed by social isolation at puberty. In this animal model will be evaluated: 1) Gene and protein expression of inflammatory signalling proteins, HDACs and the status of histone acetylation; 2) Cognitive and psychotic status by means of validated behavioural tests; 3) Modulation of cognitive responses by chronic treatment with the antipsychotic clozapine, the HDAC inhibitor SAHA and the inflammatory activity inhibitor minocycline. Cognitive responses will be related to neuroinflammatory alterations at molecular level. The findings in the animal model will be compared with those obtained in the study of neuroinflammation markers, HDACs expression and histone acetylation status in postmortem human prefrontal cortex of subjects with schizophrenia under antipsychotic treatment or drug-free conditions and matched controls. In these subjects the possibility of an excess of inflammatory activity associated to antipsychotic treatment will be analyzed.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SCHIZO-EPICOG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SCHIZO-EPICOG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

LIGHTMATT-EXPLORER (2019)

Experimental determination of the paraxial-vectorial limit of light-matter interactions

Read More  

ASIQS (2019)

Antiferromagnetic spintronics investigated by quantum sensing techniques

Read More  

INTEGRIN REGULATION (2019)

Functional analysis of the kinome and phosphatome as determinants of integrin phosphorylation in cancer

Read More